Skip to main content
Header image

Ondra Martin M.Sc.

Journals

ONDRA, M., L. LENART, A. CENTORAME, D. DUMUT, A. HE, S. ZAIDI, J. HANRAHAN, J. DE SANCTIS, D. RADZIOCH, M. HAJDÚCH
CRISPR/Cas9 bioluminescence-based assay for monitoring CFTR trafficking to the plasma membrane. Life Science Alliance. 2023, 7(1), e202302045, ISSN: 2575-1077, PMID: 37918963,
KUBÍČKOVÁ, A., Z. MACEČKOVÁ, P. VOJTA, M. ONDRA, J. VOLEJNÍKOVÁ, P. KOŘALKOVÁ, A. JUNGOVA, O. JAHODA, R. MOJZIKOVA, I. HADAČOVÁ, J. CERMAK, M. HORVÁTHOVÁ, D. POSPÍŠILOVÁ, M. HAJDÚCH
Missense mutation in RPS7 causes Diamond-Blackfan anemia via alteration of erythrocyte metabolism, protein translation and induction of ribosomal stress. Blood Cells, Molecules & Diseases. 2022, 97, 102690, ISSN: 1079-9796, PMID: 35871033,
KVAKOVA, K., M. ONDRA, J. SCHIMER, M. PETŘÍK, Z. NOVÝ, H. RAABOVA, M. HAJDÚCH, P. CIGLER
Visualization of Sentinel Lymph Nodes with Mannosylated Fluorescent Nanodiamonds. Advanced Functional Materials. 2022, 32(23), 2109960, ISSN: 1616-301X,

Books & book chapters

Transformation of bacteria by PCR , 1.vyd., Olomouc, Palacky University, 2021, 7, 51-56, Dedication: LO1304, ISBN: 978-80-244-6049-9,

Intellectual property

SURFACE MODIFIED PARTICLES (Cígler)
  1. Patent: CZ 309422; Granted: 28.12.2022; Ownership: Institute of Organic Chemistry and Biochemistry CAS, Palacky University Olomouc; Inventors: Hajdúch MariánJaworek HanaOndra MartinKubíčková Agáta 
  2. Published Application PCT/CZ2021/050103 under WO 2022/068982 (7.4.2022)

Status: Available

SURFACE MODIFIED PARTICLES (Cígler)

Utility Model: CZ 34808; Granted: 10.2.2021; Ownership: Institute of Organic Chemistry and Biochemistry CAS, Palacky University Olomouc; Inventors: Hajdúch Marián, Jaworek Hana, Ondra Martin, Kubíčková Agáta

Status: Available

Master mentorship

Lenart Lukáš M.Sc.

CRISPR/Cas9 as a tool for the development of a cystic fibrosis model for high throughput screening of compounds

Status: Graduated from 2021 to 2023.

Bachelor mentorship

Novák Vilém

Single-cell analysis in molecular biology

Status: Ongoing from 2024.